Bay Colony Advisors’s scPharmaceuticals SCPH Stock Holding History

Bay Colony Advisors’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,795	Closed	-$61.2K	–	538
2025 Q3	$61.2K	Hold	10,795	–	–	0.01%	505
2025 Q2	$41.1K	Buy	+10,795	New	+$33.5K	0.01%	463

Bay Colony Advisors's SCPH Position: Q4 2025 in Review

Bay Colony Advisors sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 10,795 shares — an estimated $61.2K sold.

Bay Colony Advisors first reported a position in SCPH in Q2 2025 and held it in 2 quarters. The position peaked at $61.2K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Bay Colony Advisors reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Bay Colony Advisors sold 10,795 scPharmaceuticals shares in Q4 2025, an estimated $61.2K.
Bay Colony Advisors first reported a position in scPharmaceuticals in Q2 2025 and held it in 2 quarters.
Bay Colony Advisors's scPharmaceuticals position peaked at $61.2K in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Bay Colony Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.